Order Article Reprints

Palandri F, Al-Ali HK, Guglielmelli P, Zuurman MW, Sarkar R, Gupta V. Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study. Cancers. 2023; 15(10):2859. https://doi.org/10.3390/cancers15102859

Palandri, Francesca, Haifa Kathrin Al-Ali, Paola Guglielmelli, Mike W. Zuurman, Rajendra Sarkar, and Vikas Gupta. 2023. "Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study" Cancers 15, no. 10: 2859. https://doi.org/10.3390/cancers15102859

Palandri, F., Al-Ali, H. K., Guglielmelli, P., Zuurman, M. W., Sarkar, R., & Gupta, V. (2023). Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study. Cancers, 15(10), 2859. https://doi.org/10.3390/cancers15102859